Joseph Shulman Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

RYTM Quotes by TradingView

Joseph Shulman is Chief Technical Officer of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 8,509 shares of RYTM, which is worth approximately $845,879. The most recent transaction as insider was on Feb 09, 2023, when has been sold 921 shares (Common Stock) at a price of $27.66 per share, resulting in proceeds of $25,474. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.51K
0% 3M change
Infinity% 12M change
Total Value Held $845,879

Joseph Shulman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2023
SELL
Open market or private sale
$25,474 $27.66 p/Share
921 Reduced 25.14%
2,742 Common Stock
Feb 09 2023
BUY
Exercise of conversion of derivative security
-
2,657 Added 42.04%
3,663 Common Stock
Feb 15 2022
SELL
Open market or private sale
$3,398 $6.1 p/Share
557 Reduced 35.64%
1,006 Common Stock
Feb 11 2022
BUY
Exercise of conversion of derivative security
-
1,563 Added 50.0%
1,563 Common Stock
JS

Joseph Shulman

Chief Technical Officer
Boston, MA

Track Institutional and Insider Activities on RYTM

Follow RHYTHM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RYTM